TTLL5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.999600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.338600E-01
Normal-vs-Stage2
4.474800E-01
Normal-vs-Stage3
6.719200E-01
Normal-vs-Stage4
2.351000E-01
Stage1-vs-Stage2
3.475200E-01
Stage1-vs-Stage3
5.048000E-01
Stage1-vs-Stage4
1.116810E-01
Stage2-vs-Stage3
1.077410E-01
Stage2-vs-Stage4
1.096440E-01
Stage3-vs-Stage4
1.124810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.781000E-01
Normal-vs-AfricanAmerican
8.232000E-01
Normal-vs-Asian
8.316000E-01
Caucasian-vs-AfricanAmerican
1.841820E-01
Caucasian-vs-Asian
4.260400E-01
AfricanAmerican-vs-Asian
5.827400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.602800E-01
Normal-vs-Female
5.812000E-01
Male-vs-Female
3.755000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.044400E-01
Normal-vs-Age(41-60Yrs)
2.240000E-01
Normal-vs-Age(61-80Yrs)
6.739800E-01
Normal-vs-Age(81-100Yrs)
7.157600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.001000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.490600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.700400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.996500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.471900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.492800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.052000E-01
Normal-vs-Daily Drinker
5.921000E-01
Normal-vs-Weekly Drinker
6.518800E-01
Normal-vs-Occasional Drinker
3.038400E-01
Normal-vs-Social Drinker
3.294400E-01
Non Drinker-vs-Daily Drinker
6.099800E-01
Non Drinker-vs-Weekly Drinker
8.777600E-01
Non Drinker-vs-Occasional Drinker
1.812750E-01
Non Drinker-vs-Social Drinker
6.315000E-01
Daily Drinker-vs-Weekly Drinker
7.776000E-01
Daily Drinker-vs-Occasional Drinker
4.822600E-01
Daily Drinker-vs-Social Drinker
8.517800E-01
Weekly Drinker-vs-Occasional Drinker
3.120400E-01
Weekly Drinker-vs-Social Drinker
8.462000E-01
Occasional Drinker-vs-Social Drinker
2.518800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.380200E-01
Normal-vs-Grade 2
7.091600E-01
Normal-vs-Grade 3
6.681800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.238300E-02
Grade 1-vs-Grade 3
4.922700E-03
Grade 1-vs-Grade 4
8.380200E-01
Grade 2-vs-Grade 3
3.076600E-01
Grade 2-vs-Grade 4
7.091600E-01
Grade 3-vs-Grade 4
6.681800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.938000E-01
Normal-vs-NonDiabetic
4.213000E-01
Diabetic-vs-NonDiabetic
3.249800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.769000E-01
Normal-vs-NoPancreatitis
5.197600E-01
Pancreatitis-vs-NoPancreatitis
7.728600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.315200E-01
Normal-vs-N1
4.300200E-01
N0-vs-N1
9.413900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.621800E-02
Normal-vs-TP53-NonMutant
7.656600E-01
TP53-Mutant-vs-TP53-NonMutant
4.76930000004039E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
